8 results on '"Manshi Kashyap"'
Search Results
2. Effect of early yoga practice on post stroke cognitive impairment
- Author
-
Manshi Kashyap, Nirendra K Rai, Ruchi Singh, Ankur Joshi, Abhijit R Rozatkar, Priyanka V Kashyap, Shweta Mishra, and Sofia Mudda
- Subjects
caregiver burden scale ,clinician-rated dimensions of psychosis symptom severity ,frontal assessment battery ,montreal cognitive assessment ,post-stroke cognitive impairment ,p300 ,yoga ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Background: Post-stroke cognitive impairment (PSCI) is a clinical entity that encompasses all types of cognitive impairment following an index stroke. Yoga has been proven to have a beneficial effect not only on cardiovascular risk factors but also on cognition. Hence, this study explored the PSCI spectrum and assessed the effect of yoga on PSCI. Methods: Forty stroke patients were enrolled in each yoga and control arm in this study. After the baseline assessment, control arm was administered standard care (including physiotherapy) while yoga arm received additional yoga intervention. Change in MoCA scores by 2 points in either direction, or FAB scale by 2 points at 6 months was taken as primary outcome, whereas improvement in MRS, CDPSS, CBS, and P300 values were considered as secondary outcomes. Results: Significant improvements were observed in MoCA, FAB, MRS, CPDSS, and CBS scores in both groups after 6 months. However, intergroup comparisons revealed better MoCA (25.5, IQR 22-27) and FAB scores (15.5, IQR 14-17) in yoga group compared to controls (24, IQR20-25.75) and (14, IQR12-15.75). Equivalent improvement was observed in MRS and CBS scores in both groups at 6 months; however, CDPSS score was better in yoga group (p = 0.0008). Both P300 amplitudes and latencies improved in all patients and median P300 amplitudes were significantly better in control group; however, no difference could be appreciated in P300 latencies improvement on intergroup comparisons at follow-up. Conclusion: Study reveals that early yoga intervention in stroke survivors leads to better improvement in cognitive abilities which would further facilitate in early reduction of caregiver burden.
- Published
- 2023
- Full Text
- View/download PDF
3. Study of the Biological Risk Factors for Fall in the Elderly Patients
- Author
-
Neeta Bhardwaj and Manshi Kashyap
- Subjects
elderly population ,fall ,functional dependence ,depression ,poly pharmacy ,Geriatrics ,RC952-954.6 - Abstract
Objective: To assess the biological risk factors for fall in the elderly patients (≥ 60 years) presenting to the geriatric-medical OPD in a tertiary care hospital. Methods: A cross sectional descriptive study was done at tertiary care center among elderly patients of both sex visiting Geriatric Medicine OPD from November 2015 to March 2017 after informed consent of the study participants. Patient with acute confusion state or patients requiring emergency management were not included. A sample size of 100 patients was included. After taking informed consent, Geriatric assessment was performed in the elderly with the help of internationally validated tools and biological risk factors for fall were then identified. Result: Prevalence of falls was found to be 17%. The statistically significant risk factors identified in this study include postural hypotension (p=0.017), abnormality in gait and balance (p
- Published
- 2018
4. Neuroborreliosis: Unusual clinical presentation and imaging features
- Author
-
Manshi Kashyap and Priyanka Vikas Kashyap
- Subjects
General Neuroscience ,Neurology (clinical) - Abstract
Lyme disease is a tick-borne infectious disease caused by Borrelia burgdorferi which causes a multi-organ involvement. It is endemic in North America and Europe, but not very commonly seen in India. Neurological manifestations (Lyme’s Neuroborreliosis,) can occur in both the early and late disseminated stages, and the classic triad consists of aseptic meningitis, painful radiculoneuritis, and cranial neuropathy. If untreated, it can be fatal and may lead to significant morbidity. We report a case with neuroborreliosis who developed acute onset and rapidly progressive bilateral vision loss, and we also report characteristic features on neuroimaging, including a characteristic “rounded M sign.” This unusual presentation, along with the characteristic imaging features, should be borne in mind to avoid misdiagnosis.
- Published
- 2022
- Full Text
- View/download PDF
5. Eight-and-a-half syndrome: a rare presentation
- Author
-
Tejaswini Penuboina, Smritimayee Panda, Manshi Kashyap, and Vaibhav Ingle
- Subjects
Male ,medicine.medical_specialty ,Internuclear ophthalmoplegia ,Facial Paralysis ,Infarction ,Lower motor neuron ,Brain Ischemia ,Ocular Motility Disorders ,Pons ,Fasciculus ,medicine ,Humans ,Palsy ,Ophthalmoplegia ,biology ,business.industry ,Horizontal gaze palsy ,General Medicine ,Paramedian pontine reticular formation ,Middle Aged ,medicine.disease ,biology.organism_classification ,Facial nerve ,Stroke ,medicine.anatomical_structure ,Radiology ,business - Abstract
Eight-and-a-half syndrome is a rare entity characterised by conjugate horizontal gaze palsy, ipsilateral internuclear ophthalmoplegia and ipsilateral lower motor neuron type facial palsy. It is due to a lesion affecting median longitudinal fasciculus, paramedian pontine reticular formation and facial nerve fascicle on the same side at the level of pons. The diagnosis is easily missed as it needs detailed ocular movement examination. It is mainly caused due to infarction or demyelinating conditions. We are reporting an interesting case of a 54-year-old man with right-side eight-and-a-half syndrome due to acute ischaemic stroke and ST-elevation myocardial infarction of the inferior wall.
- Published
- 2023
6. An Uncommon Case of Phenytoin Induced Pyramidal Tract Involvement. Does Phenytoin Toxicity Only Depend on Dose?
- Author
-
NirendraK Rai and Manshi Kashyap
- Subjects
Neurology ,Neurology (clinical) - Published
- 2022
- Full Text
- View/download PDF
7. Clinical profile and outcome of non-COVID strokes during pandemic and the pre pandemic period: COVID-Stroke Study Group (CSSG) India
- Author
-
Vivek Nambiar, Sathish Parkipandla, Rajsrinivas Parthasarathy, Praveen Panicker, S Kumaravelu, Rajeshwar Sahonta, Rohit Bhatia, Kamal Kajal, Girish Baburao Kulkarni, Vijaya Pamidimukkala, Manshi Kashyap, Githin Benoy George, A V R Taallapalli, Dheeraj Khurana, Ajay Garg, P N Sylaja, Thomas Iype, Rakesh Singh, Hiral Halani, Ayush Agarwal, Ashish Duggal, Nirendra Rai, Sritheja Reddy, Salil Gupta, Vipul Gupta, Roopa Rajan, Shailesh Gaikwad, Anu Gupta, Sapna Erat Sreedharan, P M Yogeesh, Snigdha Komakula, Leve Joseph, Vivek Lal, Arvind Sharma, M V Padma Srivastava, Prashant Dixit, Ashish Datt Upadhyay, Mamta Singh, Pranjal Gupta, Debashish Chowdhury, Sucharita Ray, Jayanta Roy, Vibhor Pardasani, Mamta Parmar, Vamsi Chalasani, Deepti Vibha, Suman Kushwaha, Krishna Sreela, Rajshekar Reddy, Harsh Oza, Biswamohan Misra, Chirag Kamal Ahuja, Sudheer Pachipala, A.K. Pandit, Jeyaraj D Pandian, Srinivasareddy Sanivarapu, Srijithesh P. Rajendran, Manish Salunkhe, Venugopalan Y Vishnu, M K Suresh, Vikas Suri, and Dileep Ramachandran
- Subjects
medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,rTPA, Recombinant Tissue Plasminogen Activator ,medicine.medical_treatment ,CVT, Cerebral Venous Thrombosis ,CSSG, COVID-19 Stroke Study Group ,India ,Stroke care ,Article ,Time-to-Treatment ,TNK, Tenecteplase ,Pandemic ,medicine ,Humans ,Endovascular treatment ,Stroke ,Pandemics ,Retrospective Studies ,COVID-19, Coronavirus disease 2019 ,Ischemic stroke ,RTPCR, Real Time Polymerase Chain Reaction ,business.industry ,SARS-CoV-2 ,NIHSS, National Institutes of Health Stroke Scale ,COVID-19 ,mRS, modified Rankin score ,Retrospective cohort study ,Thrombolysis ,CT, Computed Tomography ,SD, Standard Deviation ,ICH, Intracerebral Hemorrhage ,medicine.disease ,Door to needle time ,Neurology ,Emergency medicine ,Communicable Disease Control ,EVT, Endovascular Therapy ,IQR, Inter-quartile range ,LVO, Large Vessel Occlusion ,Neurology (clinical) ,ASPECTS, Alberta stroke program early CT score ,business - Abstract
Background As the health systems around the world struggled to meet the challenges of COVID-19 pandemic, care of many non-COVID emergencies was affected. Aims The present study examined differences in the diagnosis, evaluation and management of stroke patients during a defined period in the ongoing pandemic in 2020 when compared to a similar epoch in year 2019. Methods The COVID stroke study group (CSSG) India, included 18 stroke centres spread across the country. Data was collected prospectively between February and July 2020 and retrospectively for the same period in 2019. Details of demographics, stroke evaluation, treatment, in-hospital and three months outcomes were collected and compared between these two time points. Results A total of 2549 patients were seen in both study periods; 1237 patients (48.53%) in 2019 and 1312 (51.47%) in 2020. Although the overall number of stroke patients and rates of thrombolysis were comparable, a significant decline was observed in the month of April 2020, during the initial period of the pandemic and lockdown. Endovascular treatment reduced significantly and longer door to needle and CT to needle times were observed in 2020. Although mortality was higher in 2020, proportion of patients with good outcome were similar in both the study periods. Conclusions Although stroke admissions and rates of thrombolysis were comparable, some work flow metrics were delayed, endovascular stroke treatment rates declined and mortality was higher during the pandemic study period. Reorganization of stroke treatment pathways during the pandemic has likely improved the stroke care delivery across the globe.
- Published
- 2021
8. Lithium use in the elderly demands caution and vigilance
- Author
-
Vivek Suman and Manshi Kashyap
- Subjects
Drug ,medicine.medical_specialty ,medicine.drug_class ,media_common.quotation_subject ,Mood stabilizer ,Disease ,Biology ,Affect (psychology) ,Therapeutic index ,Pharmacokinetics ,Toxicity ,medicine ,Intensive care medicine ,media_common ,Vigilance (psychology) - Abstract
Lithium is a popular drug in the field of psychiatry, used widely as a mood stabilizer in bipolar affective disorder. However, it has a narrow therapeutic index, between 0.6 and 1.5 mEq/L. Toxicity can occur at levels >1.5 mEq/L, hence thus monitoring of serum drug level is vital. Furthermore, the range of Lithium's therapeutic index can be further lower in the elderly, especially in the presence of renal disease, as the drug metabolism in this age group has considerable variation from an average adult. Following is a case report to exemplify Lithium Intoxication and of its narrow therapeutic index; and to develop further understanding on and the clinical implications of the age related changes that affect the pharmacokinetics and pharmacodynamics of the drug.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.